A multicultural group practicing yoga together in a bright studio

Ro vs TMates: GLP-1 Comparison 2026

Ro vs TMates: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated September 5, 20264 min read

Quick answer

Ro is a coaching-heavy, brand-name-leaning program; TMates is a more medication-first telehealth experience. Choose Ro if you want behavior-change structure; choose TMates if you want straightforward GLP-1 access.

Side-by-side comparison

Feature	Ro	TMates
Best for	Brand-name access with a polished telehealth UX	Compounded GLP-1 with hands-on clinical touch
Medication type	Brand-name Wegovy and Zepbound; some compounded options	Compounded GLP-1 with bundled clinical support
Pricing model	Membership + medication; insurance-friendly	Monthly subscription, dose-tier pricing
Semaglutide price	Membership $149/mo ($74/mo on annual prepay, $39 first month applies to the membership); Wegovy pill from $149/mo at the entry dose, rising by dose to $299/mo, billed separately (re-read 2026-08-20 on ro.co/weight-loss/pricing: 'Starting at $149/mo', 'See all dose prices')	From $158/mo (compounded semaglutide, 12-month plan; $249/mo month-to-month); medication and visits included
Tirzepatide price	Membership $149/mo ($74/mo on annual prepay, $39 first month applies to the membership); Zepbound KwikPen from $299/mo at the entry dose, rising by dose to $449/mo, billed separately (re-read 2026-08-20 on ro.co/weight-loss/pricing: 'Starting at $299/mo', 'See all dose prices')	From $167/mo (compounded tirzepatide, 12-month plan; $297/mo month-to-month)
Key watchout	Brand-name medication is expensive without insurance, confirm coverage first	The $158 headline is the compounded SEMAGLUTIDE plan (12-month term; $249/mo month-to-month). Tirzepatide costs more ($167/mo on a 12-month plan, $297 month-to-month), confirm your product and term at checkout
Price checked	Checked by a person September 5, 2026 · an automated check re-read it September 21, 2026	Checked by a person July 14, 2026 · an automated check re-read it September 21, 2026

When to choose Ro

You want brand-name Wegovy or Zepbound, not compounded
You have insurance and want help running prior authorization
You value a strong app and ongoing clinical messaging
You're willing to pay a higher all-in price for the brand-name path

Check current Ro pricing →

When to choose TMates

You want a compounded program with clinical check-ins built in
You'd rather pay one bundled monthly fee than line items
You want responsive messaging with prescribers
You're comfortable with a longer onboarding intake in exchange for support

Check current TMates pricing →

Full reviews

Frequently asked questions

Is Ro cheaper than TMates?

Ro starts lower on semaglutide (Membership $149/mo ($74/mo on annual prepay, $39 first month applies to the membership); Wegovy pill from $149/mo at the entry dose, rising by dose to $299/mo, billed separately (re-read 2026-08-20 on ro.co/weight-loss/pricing: 'Starting at $149/mo', 'See all dose prices')). Ro starts lower on tirzepatide (Membership $149/mo ($74/mo on annual prepay, $39 first month applies to the membership); Zepbound KwikPen from $299/mo at the entry dose, rising by dose to $449/mo, billed separately (re-read 2026-08-20 on ro.co/weight-loss/pricing: 'Starting at $299/mo', 'See all dose prices')). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Ro or TMates?

Ro starts lower on both semaglutide and tirzepatide based on listed entry pricing. That said, the right pick is the program whose support model and formulation match what you actually need.

Are Ro and TMates compounded or brand-name?

Ro offers brand-name wegovy and zepbound; some compounded options. TMates offers compounded glp-1 with bundled clinical support. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Ro to TMates?

Yes, switching between Ro and TMates is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Ro and TMates to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Membership $149/mo ($74/mo on annual prepay, $39 first month applies to the membership); Wegovy pill from $149/mo at the entry dose, rising by dose to $299/mo, billed separately (re-read 2026-08-20 on ro.co/weight-loss/pricing: 'Starting at $149/mo', 'See all dose prices') and $158/mo (compounded semaglutide, 12-month plan; $249/mo month-to-month); medication and visits included are starting tiers, not your guaranteed long-term cost.